Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

Key Takeaway: Bicycle Therapeutics provided an update on its Nuzefatide Pevedotin and EphA2 pipeline during the AACR Annual Meeting 2026. The details of the update were not disclosed in the article. Further information may be available from the event.